Moderna Inc (MRNA)
39.39
-0.17
(-0.43%)
USD |
NASDAQ |
Dec 20, 16:00
39.81
+0.42
(+1.07%)
After-Hours: 06:59
Moderna Cash from Investing (Quarterly): 721.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
| Novavax Inc | 31.91M |
| Biogen Inc | -1.181B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.566B |
| Cash from Financing (Quarterly) | 11.00M |
| Free Cash Flow | -3.956B |
| Free Cash Flow Per Share (Quarterly) | -4.303 |
| Free Cash Flow to Equity (Quarterly) | -1.717B |
| Free Cash Flow to Firm (Quarterly) | -1.717B |
| Free Cash Flow Yield | -25.97% |